AmarnaBio
PrivateLast Round
Grant
Mar 13, 2025
Total Funding Raised
$50,000
Company Overview
AmarnaBio operates in Healthcare & Life Sciences and is based in Chapel Hill, North Carolina. Its latest recorded funding round was a Grant round in March 2025.
AmarnaBio is a biotechnology company that uses an AI-driven platform to decode RNA regulatory networks for biomarker and drug target discovery, with a focus on neurological and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AmarnaBio Comparables
Compare AmarnaBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eclipsebio | 86% | |
| Envisagenics | 82% | |
| ReviR Therapeutics | 82% |
For institutional investors. Book with your work email.
AmarnaBio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
AmarnaBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KickStart Venture Services | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 13, 2025
$50K grant from KickStart Venture Services.
For institutional investors. Book with your work email.
AmarnaBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AmarnaBio's valuation, stock price, and market status.
Is AmarnaBio a public or private company?
AmarnaBio is a private company.
What is the current stock price of AmarnaBio?
AmarnaBio is a private company, so its shares have no public market price. Caplight tracks AmarnaBio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AmarnaBio worth (valuation)?
Valuation information for AmarnaBio is not publicly available.
Can I buy AmarnaBio stock?
AmarnaBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AmarnaBio's last funding round?
AmarnaBio's most recent funding round was Grant on March 13, 2025.
Who are the main investors in AmarnaBio?
Key investors in AmarnaBio include KickStart Venture Services.
Will AmarnaBio IPO soon?
No public IPO plans have been announced for AmarnaBio.
How can I track AmarnaBio secondary market activity?
Caplight tracks bids, offers, and trades in AmarnaBio's shares on secondary markets.